WILMINGTON, Del., June 18, 2007 (PRIME NEWSWIRE) -- Rx Processing Corporation (Pink Sheets:RXPC), an innovator providing affordable health care to U.S. citizens, is further ensuring safe delivery of prescription medications and laboratory testing by centralizing future operations in St. Petersburg, Florida.
The corporate actions today of centralizing and consolidating administrative and operations functions are ensuring rapid responses to clients' needs. The company sees these swift actions affording fundamental growth flexibility, with added speed to enhance shareholder transparency in a Sarbanes Oxley environment. This move is largely in part of an overall consolidation and restructuring of the company's Kansas and Delaware locations.
Peter Fiorillo commented, "We value your continued support and will take the actions necessary to meet our objectives by delivering upon fundamentals and promises made to shareholders, and we will up-list later this year than anticipated."
O/S: 63,790,891 Float: 26,181,836 Shareholders: 473
Rx Processing Corp., an innovator in the distribution of pharmaceutical medications and laboratory diagnostics managed through storefront locations, is deploying a direct to consumer delivery business model that fulfills the needs of under and uninsured clients' health care needs. The company provides access to FDA approved brand-name and generic medications, thousands of laboratory diagnostics with access to 4,000-plus CLIA-certified patient service centers for specimen collection. Rx Processing Corp. estimates that more than 48 million United States citizens would benefit from these company programs.
Safe Harbor Statement:
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including those about the company's future expectations, revenues and earnings, and all other forward-looking statements (i.e. operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.